Full text loading...
Toll-Like Receptor 4 (TLR4) is vital for the innate immune system as it recognizes a wide array of pathogens, such as bacteria, fungi, and viruses. TLR4 activates downstream signaling pathways upon recognizing microbial components, triggering and regulating the immune response. With improvements in genomic technologies, it has become possible to identify Single-Nucleotide Polymorphisms (SNPs) in genes coding for immune receptors, such as TLR4. These genetic differences may affect the way TLR4 reacts to various pathogens and thus the intensity and outcome of immune responses. It is essential to have a comprehensive understanding of SNPs associated with TLR4 to assess individual susceptibility to infection and inform personalized medicine strategies.
Multiple scientific literature review databases were utilized to examine TLR4 SNPs and their roles in pathogen recognition, immune signaling, and disease outcomes. These studies elaborated the role of TLR4 polymorphisms in various forms of infections involving bacteria, fungi, and viruses.
Some polymorphisms in the TLR4 gene, including rs4986790 [Asp299Gly] and rs4986791 [Thr399Ile], have been associated with differing immune responses and increased susceptibility to septic shock, candidiasis, tuberculosis, and viral infections. This inhibition of TLR4 signaling by the mutant alleles augments some arms of immune response while inhibiting others, which in turn affects the severity of the infection and the response to treatment.
This review focuses on the identification and examination of SNPs in TLR4 and their association with infectious diseases caused by pathogens. The review also examines the impact of these SNPs on TLR4 signaling pathways and the immune response. Polymorphisms in the TLR4 gene, including rs4986790 [Asp299Gly] and rs4986791 [Thr399Ile], have been associated with differing immune responses and increased susceptibility to septic shock, candidiasis, tuberculosis, and viral infections.
Recognition of TLR4 SNPs would provide information on susceptibility to various infections and immune modulation. Current knowledge of genetic variations will lead to the identification of biomarkers for infectious diseases, and consequently, patient-specific treatment and vaccine generation targeted toward specific genotypes in precision medicine, particularly in immunology.
Article metrics loading...
Full text loading...
References
Data & Media loading...